Theriva Biologics, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Theriva Biologics, Inc. stock issued during period, shares, new issues for the quarter ending 2024-03-31 was 0.00 shares.
- Theriva Biologics, Inc. stock issued during period, shares, new issues for the quarter ending 2023-03-31 was 0.00 shares.
- Theriva Biologics, Inc. stock issued during period, shares, new issues for the quarter ending 2022-12-31 was 0.00 shares.
- Theriva Biologics, Inc. stock issued during period, shares, new issues for the quarter ending 2022-09-30 was 0.00 shares.
- Theriva Biologics, Inc. stock issued during period, shares, new issues for fiscal 2022 was 0.00 shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-07 | |
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-07 | 0.00 shares derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 0.00 shares 10-K · filed 2024-03-25 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-16 | |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | |
| 2021-06-30 | 70.80M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | |
| 2021-03-31 | 7.90M shares 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |